who should not take bpc 157 What is BPC-157? BPC-157 vs TB-500: Recovery Peptide

You may also see it written as BPC-157 or referred to more broadly as a healing peptide

Preclinical findings show measurable increases in microvessel density at BPC-157-treated wound sites compared to control groups within 7 to 14 days of administration

BPC 157, also known as Bepecin, PL 14736, and PL10, is a pentadecapeptide (15 amino acids long)

It depends on your body's ability to absorb B12

Patients with complex medical histories, unexplained symptoms, pregnancy considerations, immune disorders, active cancer concerns, severe allergies, medication interactions, or competitive sport obligations should avoid self-directed use and seek medical guidance